SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-122334
Filing Date
2021-10-04
Accepted
2021-10-04 09:10:43
Documents
1
Period of Report
2021-09-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2129153-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2129153-2_3seq1.xml 3 4248
  Complete submission text file 0001104659-21-122334.txt   6547
Mailing Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070
Business Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070 9732354295
ROCHE HOLDING LTD (Reporting) CIK: 0000889131 (see all company filings)

State of Incorp.: V8
Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 211301210
SIC: 8880 American Depositary Receipts

Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Reporting) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 211301209

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)